Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. (Q37077655)

18 August 2017

1 reference

title

Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. (English)

1 reference

pneumococcal conjugate vaccine

18 August 2017

0 references

1 reference

1 reference

1

Carlos G Grijalva

1 reference

18 August 2017

2

Marie R Griffin

1 reference

18 August 2017

publication date

1 February 2008

1 reference

Expert Review of Vaccines

18 August 2017

published in

1 reference

18 August 2017

volume

7

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

83-95

1 reference

Estimates of world-wide distribution of child deaths from acute respiratory infections

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Community acquired pneumonia--a prospective UK study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Diagnosis and management of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Trends in otitis media among children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

The potential effect of widespread use of pneumococcal conjugate vaccines on the practice of pediatric otolaryngology: the case of acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Pneumococcal vaccination in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

The potential indirect effect of conjugate pneumococcal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

A role for Streptococcus pneumoniae in virus-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Impact of the pneumococcal conjugate vaccine on otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Policy and program analysis using administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Population-based impact of pneumococcal conjugate vaccine in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Changes in frequency and pathogens causing acute otitis media in 1995-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.1.83

21 January 2018

Identifiers

DOI

10.1586/14760584.7.1.83

1 reference

18 August 2017

1 reference